Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H20N6S |
InChIKeyLZKXCQQNNYURRI-UHFFFAOYSA-N |
CAS Registry2408789-95-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Jan 2020 |